HOME >> BIOLOGY >> NEWS
Other highlights in the November 3 JNCI

Method Could Improve Irinotecan Chemotherapy Effectiveness

Assessing how quickly the body metabolizes the drug midazolam combined with genotyping could help to optimize irinotecan chemotherapy, according to a new study.

Irinotecan has been approved for use as part of first- and second-line chemotherapy for colorectal cancer and also has moderate activity against breast cancer, relapsed or refractory non-Hodgkin lymphoma, and lung cancer. Response to the drug varies in different people because of variations in the enzymes that metabolize the drug, including cytochrome P450 3A4 (CYP3A4) and uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1).

Alex Sparreboom, Ph.D., of the National Cancer Institute, and colleagues demonstrated in 30 cancer patients that the speed at which the body metabolizes the drug midazolam was associated with CYP3A4 phenotype and is closely related to how quickly the body metabolizes irinotecan. They also found that a specific UGT1A1 mutation was associated with increased amounts of the active inrinotecan metabolite. They conclude that combining CYP3A4 phenotyping with UGT1A1 genotyping could assist with the optimization of irinotecan chemotherapy. The method is currently undergoing validation in a prospective study.

Contact: National Cancer Institute Press Office, 301-496-6641, NCIPressOfficers@mail.nih.gov

Height, Obesity, and Activity Level Associated With Endometrial Cancer Risk

Greater height and obesity and lower levels of physical activity are all associated with an increased risk of endometrial cancer, according to a new study.

Obesity is an established risk factor for endometrial cancer, and there has been some evidence that body mass at younger ages, weight change, height, and physical activity may also be associated with a woman's risk of this cancer. To investigate these possible associations, Leo J. Schouten,
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
2-Nov-2004


Page: 1 2 3 4

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights from the March 21 JNCI
10. Other highlights in the March 7 JNCI
11. Other highlights in the Feb. 21 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/13/2019)... EGG HARBOR, N.J. (PRWEB) , ... March 13, 2019 , ... ... detection systems for the Pharmaceutical, Biotechnology and Medical Device Industries, is excited to announce ... changed ownership in early February 2019 and the newly installed and highly experienced ...
(Date:3/11/2019)... ... 11, 2019 , ... A new report published by the Family Equality Council ... 77% of those aged 18 to 35 already have or are considering having children, ... and older.(1) Among all LGBTQ prospective parents, 41% are considering assisted reproductive technology (ART) ...
(Date:3/9/2019)... MURRIETA, Calif. (PRWEB) , ... March 07, 2019 , ... ... sponsor of a full day workshop presented by University of California Riverside’s ... being held from 8 a.m. to 6 p.m. on Tuesday, March 17, 2019. The ...
Breaking Biology News(10 mins):
(Date:3/12/2019)... (PRWEB) , ... March 11, 2019 , ... ... first hospital system in Colorado, and among the first in the nation, to ... around lab draws, IV placement and overall degree to which staff showed compassion ...
(Date:3/9/2019)... ... March 07, 2019 , ... ACEA Biosciences Inc. ... and commercialization of high performance, cutting-edge cell analysis platforms for life science research. ... expertise in cardiovascular pharmacology and electrophysiology, are announcing a partnership to provide comprehensive ...
(Date:3/4/2019)... ... 04, 2019 , ... Stay on top of current hot topics through free webinars presented by ... free, so be sure to register today to save your place! Participate in the discussion ... webinars: , CLINICAL TRIALS, , March 20 – Implementing BYOD Across ...
(Date:2/22/2019)... , ... February 20, 2019 , ... ... SeqOnce , an emerging leader in the rapidly growing NGS (Next Generation Sequencing) ... the Murrieta Genomics laboratory and incubator. , "As an innovation center and idea ...
Breaking Biology Technology:
Cached News: